Complete AI committee score history · 14 sessions recorded · Updated nightly
| Date | Score | Rating | Recommendation | Conviction | Agreement | Analysts |
|---|---|---|---|---|---|---|
| 2026-07-29 | 59.8 | Buy | Buy | Contested | 43% | 7 |
| 2026-07-28 | 59.8 | Buy | Buy | Contested | 43% | 7 |
| 2026-07-27 | 62.7 | Buy | Buy | Contested | 57% | 7 |
| 2026-07-26 | 62.7 | Buy | Buy | Contested | 57% | 7 |
| 2026-07-25 | 62.1 | Buy | Buy | Contested | 57% | 7 |
| 2026-07-24 | 62.1 | Buy | Buy | Contested | 57% | 7 |
| 2026-07-23 | 62.1 | Buy | Buy | Contested | 57% | 7 |
| 2026-07-22 | 62.1 | Buy | Buy | Contested | 57% | 7 |
| 2026-07-21 | 62.1 | Buy | Buy | Contested | 57% | 7 |
| 2026-07-20 | 62.1 | Buy | Buy | Contested | 57% | 7 |
| 2026-07-19 | 62.1 | Buy | Buy | Contested | 57% | 7 |
| 2026-07-18 | 62.1 | Buy | Buy | Contested | 57% | 7 |
| 2026-07-17 | 63.3 | Buy | Buy | Contested | 57% | 7 |
| 2026-07-16 | 59.8 | Buy | Watch | Moderate | 71% | 7 |
About This Data
Committee scores are generated nightly by Innellis's 7-analyst AI committee. Each session analysts independently score West Pharmaceutical Services across fundamentals, momentum, and risk — then debate and reach a consensus. Scores range from 0 (most bearish) to 100 (most bullish). View track record →